Feb 17 () - Disc Medicine said ‌on Tuesday it ‌will pursue a traditional ​U. approval pathway for its rare disease drug ...
FDA decision puts pelareorep in focus Oncolytics Biotech (NasdaqCM:ONCY) is back on investor radars after the FDA granted Fast Track Designation to pelareorep in a combination regimen for second line ...
Congress has until Friday to reach a deal to fund the Department of Homeland Security. And, several asylum cases filed by Somali migrants in immigration courts were suddenly fast-tracked.